Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study)

INTRODUCTION: Scabies is a significant contributor to global morbidity, affecting approximately 200 million people at any time. Scabies is endemic in many resource-limited tropical settings. Bacterial skin infection (impetigo) frequently complicates scabies infestation in these settings. Community-w...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMJ Open
Main Authors: Lake, Susanna J, Phelan, Sophie L, Engelman, Daniel, Sokana, Oliver, Nasi, Titus, Boara, Dickson, Gorae, Christina, Schuster, Tibor, Grobler, Anneke C, Osti, Millicent H, Andrews, Ross, Marks, Michael, Whitfeld, Margot J, Romani, Lucia, Kaldor, John, Steer, Andrew
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2020
Teme:
Global Health
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7462236/
https://ncbi.nlm.nih.gov/pubmed/32868360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-037305
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki